What are the ADS guidelines for use of HbA1c in the management of type 1 diabetes mellitus (DM)?

Updated: Jul 28, 2020
  • Author: Romesh Khardori, MD, PhD, FACP; Chief Editor: George T Griffing, MD  more...
  • Print
Answer

ADA guidelines recommend measuring HbA1c at least every 6 months year in patients who are meeting treatment goals and who have stable glycemic control. For patients whose therapy has changed or who are not meeting glycemic goals, the guidelines recommend HbA1c testing every 3 months. [5]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!